Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
0.3 mL delivers the same dose at a lower concentration
During the first 2-3 weeks of BPC-157 treatment, minimize repetitive wrist motions and activities that reproduce pain
Decrease dose if: Experiencing consistent side effects (headaches, fatigue, GI disturbance), achieving satisfactory results at current dose with no need for escalation, or cost considerations favor using minimum effective dose
Key Research Attributes Premium research-grade Somatropin HGH 191AA (24 IU) Structurally identical to endogenous human growth hormone Studied extensively in growth hormone and IGF-1 signaling research Explored in profound metabolic regulation and cellular growth models Investigated for critical roles in tissue repair, recovery, and endocrine adaptation Intended strictly for in-vitro and controlled laboratory research use This compound remains one of the most extensively researched hormones in endocrine biology due to its remarkably broad physiological relevance and well-established mechanisms of action
C9399 (Unclassified drugs or biologicals) is used in hospital outpatient settings under the Outpatient Prospective Payment System (OPPS)
US$ 27.61
US$ 26.96
US$ 24.13
US$ 28.25
